biote Corp. (BTMD) director Barrera receives 121,452 stock options at $2.20

Rhea-AI Filing Summary

biote Corp. director and ten percent owner Richard R. Barrera received a grant of stock options for 121,452 shares of Class A Common Stock at an exercise price of $2.20 per share. The options vest on the earlier of May 12, 2027 or the day before the 2027 Annual Meeting of Stockholders and expire on May 11, 2036.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Barrera Richard R

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	121,452	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 121,452 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 121,452 options Exercise price: $2.20 per share Shares after transaction: 121,452 derivative shares +2 more

5 metrics

Option grant size 121,452 options Stock Option (Right to Buy) for Class A Common Stock

Exercise price $2.20 per share Conversion or exercise price of stock options

Shares after transaction 121,452 derivative shares Total shares following transaction for this award

Vesting date May 12, 2027 or earlier meeting-related date Vests on earlier of May 12, 2027 or day before 2027 Annual Meeting

Option expiration May 11, 2036 Expiration date of the stock option award

Key Terms

Stock Option (Right to Buy), Class A Common Stock, Grant, award, or other acquisition, Annual Meeting of Stockholders, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title": "Stock Option (Right to Buy)""

Class A Common Stock financial

"underlying_security_title": "Class A Common Stock""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Annual Meeting of Stockholders financial

"the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's"

continuous service financial

"subject to the Reporting Person's continuous service through such vesting date."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Barrera Richard R

(Last) (First) (Middle)

C/O BIOTE CORP.

1875 W. WALNUT HILL LN #100

(Street)

IRVING TEXAS 75038

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
biote Corp. [ BTMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.2	05/12/2026		A		121,452		(1)	05/11/2036	Class A Common Stock	121,452	$0.00	121,452	D

Explanation of Responses:

1. All shares subject to the option award shall vest on the earlier of May 12, 2027 or the day prior to the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Remarks:

	/s/ Kendal McNeely, as Attorney-in-Fact for Richard R. Barrera	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did biote Corp. (BTMD) insider Richard R. Barrera report on this Form 4?

Richard R. Barrera reported receiving a stock option grant for 121,452 shares of biote Corp. Class A Common Stock. The options were awarded at a $2.20 exercise price per share and represent a compensation-related acquisition, not an open-market purchase or sale.

How many biote Corp. (BTMD) shares are covered by Barrera’s new stock options?

The stock option grant covers 121,452 shares of biote Corp. Class A Common Stock. Following the grant, Barrera’s reported derivative holdings from this award total the same 121,452 options, all tied to the $2.20 per-share exercise price disclosed.

What is the exercise price of Richard R. Barrera’s biote Corp. stock options?

The stock options granted to Richard R. Barrera have an exercise price of $2.20 per share. This means he can purchase each underlying share of Class A Common Stock at $2.20, regardless of the market price when he chooses to exercise the options.

When do Richard R. Barrera’s biote Corp. stock options vest?

All shares subject to the option award vest on the earlier of May 12, 2027 or the day prior to biote Corp.’s 2027 Annual Meeting of Stockholders. Vesting is conditioned on Barrera’s continuous service through the applicable vesting date.

When do Richard R. Barrera’s biote Corp. stock options expire?

The granted stock options expire on May 11, 2036. After that expiration date, Barrera will no longer be able to exercise the options at the $2.20 exercise price for the 121,452 underlying shares of Class A Common Stock.

Is Barrera’s Form 4 transaction a market buy or sell of biote Corp. shares?

The Form 4 reflects a grant or award acquisition of stock options, coded as transaction type “A.” It is a compensation-related option grant at no purchase price, not an open-market buy or sell of existing biote Corp. Class A Common Stock shares.